UNH Leads Healthcare Stocks with Strong Q2 Earnings and Bullish Consensus
UnitedHealth Group Incorporated (UNH), a healthcare company based in Eden Prairie, Minnesota, has been a standout performer on Wall Street. With a market value of $369.7 billion, UNH operates through four segments: Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare.
The stock has outpaced the broader market over the past year, surging 62.9% compared to the S&P 500 Index's ($SPX) 21.3% gain. In 2026, UNH has risen by nearly 23.8%, also rallying above SPX's 13.3% gain.
The State Street Healthcare Select Sector SPDR ETF (XLV) has underperformed the stock over the past year, rising only 29.4%. However, in 2026, XLV has surged 8.8% and lagged behind UNH.
On July 16, UNH stock rose 1.2% following the release of its better-than-expected Q2 2026 earnings. The company's revenue for the quarter came in at $112.03 billion and surpassed the Street's forecasts. Its adjusted EPS amounted to $6.38, also topping Wall Street's estimates.
UNH expects full-year earnings in the range of $19.50 to $20 per share. For the current year, analysts expect UNH's EPS to rise 20.4% to $19.69 on a diluted basis. The company has surpassed the consensus estimate in each of the last four quarters.
Among the 26 analysts covering UNH stock, the consensus is a 'Strong Buy.' That's based on 20 'Strong Buy' ratings, three 'Moderate Buys,' and three 'Holds.'